Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.

We conducted a meta-analysis of published randomized, placebo-controlled clinical trials that evaluated the effect of pharmacotherapy in patients with borderline personality disorder. Comprehensive searches of the MEDLINE, EMBASE, PsychLIT and Cochrane Central Register of Controlled Trials databases...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Nosè, M, Cipriani, A, Biancosino, B, Grassi, L, Barbui, C
Materiálatiipa: Journal article
Giella:English
Almmustuhtton: 2006
_version_ 1826269609631678464
author Nosè, M
Cipriani, A
Biancosino, B
Grassi, L
Barbui, C
author_facet Nosè, M
Cipriani, A
Biancosino, B
Grassi, L
Barbui, C
author_sort Nosè, M
collection OXFORD
description We conducted a meta-analysis of published randomized, placebo-controlled clinical trials that evaluated the effect of pharmacotherapy in patients with borderline personality disorder. Comprehensive searches of the MEDLINE, EMBASE, PsychLIT and Cochrane Central Register of Controlled Trials databases were performed using web-based search engines. Twenty articles, reporting 22 placebo-controlled comparisons, were included in the meta-analysis: eight involved antipsychotics, seven antidepressants and seven mood stabilizers. Antidepressants (four studies, standardized mean difference -0.55, 95% confidence interval -0.92, -0.17) and mood stabilizers (six studies, standardized mean difference -1.74, 95% confidence interval -2.76, -0.73) were effective against affective instability and anger, but did not produce significant benefits against impulsivity and aggression, unstable relationships, suicidality and global functioning. Antipsychotics as a class had a positive effect in terms of impulsivity and aggression (three studies, standardized mean difference -0.31, 95% confidence interval -0.63, -0.003), interpersonal relationships (three studies, standardized mean difference -0.52, 95% confidence interval -0.87, -0.17) and global functioning (seven studies, standardized mean difference -0.56, 95% confidence interval -1.00, -0.11). No difference was observed between pharmacotherapy and placebo in terms of participants leaving the study early. Pharmacotherapy can exert a modest beneficial effect on some core traits of borderline personality disorder.
first_indexed 2024-03-06T21:27:45Z
format Journal article
id oxford-uuid:43a87b91-e1ed-4567-b983-dbef77ec207c
institution University of Oxford
language English
last_indexed 2024-03-06T21:27:45Z
publishDate 2006
record_format dspace
spelling oxford-uuid:43a87b91-e1ed-4567-b983-dbef77ec207c2022-03-26T14:56:48ZEfficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:43a87b91-e1ed-4567-b983-dbef77ec207cEnglishSymplectic Elements at Oxford2006Nosè, MCipriani, ABiancosino, BGrassi, LBarbui, CWe conducted a meta-analysis of published randomized, placebo-controlled clinical trials that evaluated the effect of pharmacotherapy in patients with borderline personality disorder. Comprehensive searches of the MEDLINE, EMBASE, PsychLIT and Cochrane Central Register of Controlled Trials databases were performed using web-based search engines. Twenty articles, reporting 22 placebo-controlled comparisons, were included in the meta-analysis: eight involved antipsychotics, seven antidepressants and seven mood stabilizers. Antidepressants (four studies, standardized mean difference -0.55, 95% confidence interval -0.92, -0.17) and mood stabilizers (six studies, standardized mean difference -1.74, 95% confidence interval -2.76, -0.73) were effective against affective instability and anger, but did not produce significant benefits against impulsivity and aggression, unstable relationships, suicidality and global functioning. Antipsychotics as a class had a positive effect in terms of impulsivity and aggression (three studies, standardized mean difference -0.31, 95% confidence interval -0.63, -0.003), interpersonal relationships (three studies, standardized mean difference -0.52, 95% confidence interval -0.87, -0.17) and global functioning (seven studies, standardized mean difference -0.56, 95% confidence interval -1.00, -0.11). No difference was observed between pharmacotherapy and placebo in terms of participants leaving the study early. Pharmacotherapy can exert a modest beneficial effect on some core traits of borderline personality disorder.
spellingShingle Nosè, M
Cipriani, A
Biancosino, B
Grassi, L
Barbui, C
Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.
title Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.
title_full Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.
title_fullStr Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.
title_full_unstemmed Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.
title_short Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.
title_sort efficacy of pharmacotherapy against core traits of borderline personality disorder meta analysis of randomized controlled trials
work_keys_str_mv AT nosem efficacyofpharmacotherapyagainstcoretraitsofborderlinepersonalitydisordermetaanalysisofrandomizedcontrolledtrials
AT cipriania efficacyofpharmacotherapyagainstcoretraitsofborderlinepersonalitydisordermetaanalysisofrandomizedcontrolledtrials
AT biancosinob efficacyofpharmacotherapyagainstcoretraitsofborderlinepersonalitydisordermetaanalysisofrandomizedcontrolledtrials
AT grassil efficacyofpharmacotherapyagainstcoretraitsofborderlinepersonalitydisordermetaanalysisofrandomizedcontrolledtrials
AT barbuic efficacyofpharmacotherapyagainstcoretraitsofborderlinepersonalitydisordermetaanalysisofrandomizedcontrolledtrials